In the same study, silencing GLI2 and GLI1 expression in AML cells using the GLI inhibitor GANT61 led to a marked increase in apoptosis, reduced cell proliferation, and a diminished colony-forming capacity of AML cells [8]. Here, GLI1 is linked to acute myeloid leukemia.